‘A significant departure’: Former Kentucky researcher faked 28 figures in grant applications and papers, say Feds

A former researcher at the University of Kentucky committed misconduct in both published papers and grant applications, according to a federal watchdog. The finding from the Office of Research Integrity (ORI) comes two years after the University of Kentucky announced that it had concluded that the scientist, Stuart Jarrett, had committed misconduct on four papers … Continue reading ‘A significant departure’: Former Kentucky researcher faked 28 figures in grant applications and papers, say Feds

Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server

The overseers of the preprint server SocArXiv have withdrawn a paper which claims that treating Covid patients with ivermectin dramatically reduces their odds of hospitalization, calling the work “misleading” and “part of an unethical program by the government of Mexico City to dispense hundreds of thousands of doses of an inappropriate medication to people who … Continue reading Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server

Authors who don’t disclose conflicts of interest? “[W]e cannot force them to do so,” says editor

Do journal editors have the responsibility to ensure authors are disclosing relevant conflicts of interest? According to the editor of  one Elsevier journal, the answer is “no.” The case marks the second time this year that the editor of an Elsevier journal has been less than dogged about enforcing the company’s clearly stated policies about … Continue reading Authors who don’t disclose conflicts of interest? “[W]e cannot force them to do so,” says editor

Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

One of China’s leading scientists in the fight against COVID-19 failed to disclose ties to a pharmaceutical company in a paper stemming from a clinical trial, Retraction Watch has learned. A co-author on the paper is married to the daughter of that pharmaceutical company’s founder, who herself sits on the firm’s board of directors.  Nanshan … Continue reading Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

Authors retract Nature Majorana paper, apologize for “insufficient scientific rigour”

The authors of a Nature paper that could have meant a great leap forward for Microsoft’s computing power are retracting it today after other researchers flagged serious problems in the work. The researchers, led by Leo Kouwenhoven, a physicist at Delft Technical University in the Netherlands who is also employed by Microsoft, published “Quantized Majorana … Continue reading Authors retract Nature Majorana paper, apologize for “insufficient scientific rigour”

Researchers face disciplinary action as dozens of their studies fall under scrutiny

A group of obstetrics researchers in the Middle East is facing disciplinary action after questions were raised about the validity of the data in dozens of their published studies.  The tale — involving contaminated clinical trials, potentially fabricated PhDs, findings of misconduct that went ignored, accusations of terrorist sympathies and unresponsive journals — requires some … Continue reading Researchers face disciplinary action as dozens of their studies fall under scrutiny

Better (publishing) background checks: A way toward greater integrity in science

Science represents perhaps the single greatest accomplishment of humankind. Of all human institutions, organisations and establishments, science has proven an effective tool for driving progress. It is inherently self-correcting, and tolerates — and even demands — skepticism, challenge and self-critique. Few human institutions can make a similar claim. However, there is increasing recognition and concern that … Continue reading Better (publishing) background checks: A way toward greater integrity in science

Weekend reads: The scale of misconduct in China; toxic peer reviews; license to publish?; an editorial revolt

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a researcher at Northwestern who’s up to five retractions; a … Continue reading Weekend reads: The scale of misconduct in China; toxic peer reviews; license to publish?; an editorial revolt

Weekend reads: Unauthorized vaccine trial leads to criminal investigation; outrage over a skeleton study; how much plagiarism is OK?

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support it? Thanks in advance. The week at Retraction Watch featured a look at how likely it is for researchers who … Continue reading Weekend reads: Unauthorized vaccine trial leads to criminal investigation; outrage over a skeleton study; how much plagiarism is OK?